15 results
8-K
ATHA
Athira Pharma Inc
17 May 24
Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action
5:00pm
plaintiff service awards. The Order set a final approval hearing for Thursday, July 18, 2024, at 10:30 am.
As required by the Order, the Company issued
8-K
EX-99.1
ATHA
Athira Pharma Inc
17 May 24
Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action
5:00pm
plaintiff service awards.
The order set a final approval hearing for Thursday, July 18, 2024, at 10:30 am. As required by the order, the following
8-K
EX-10.1
ATHA
Athira Pharma Inc
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
CAPACITY, AND NOT AS A PLAINTIFF, REPRESENTATIVE, OR CLASS MEMBER IN ANY PURPORTED CLASS, COLLECTIVE, OR REPRESENTATIVE LAWSUIT OR PROCEEDING
8-K
EX-10.3
51lix5
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
- Prev
- 1
- Next